StockNews.AISignal intelligence
Company intelligence

SYK

Stryker Corporation · NYSE · Healthcare

Price$330.27-0.10% · −$0.32
Market cap126.61BEquity value
P / E24.7Trailing ratio
Volume461.98KLatest session
Market data

SYK price chart

TradingView
Related signals
1 min delayed

Browse public SYK signals with their source context and measured market impact. Open any signal for its permanent analysis page.

SYKJul 30, 2026-6.51% since signal

Stryker tops Q2 estimates on strong spinal and orthopedic implant demand

Stryker posted a stronger-than-expected second quarter, driven by robust demand for implants and devices used in complex spinal and orthopedic surgeries. The catalyst is sustained demand for high-end surgical products, suggesting continued revenue momentum into the second half. If the trend persists, the results could support margins and lift near-term investor sentiment for SYK.

View signal analysis
SYKJun 18, 2026+2.21% since signal

Stryker slips after earnings as PT is trimmed amid market chatter

Stryker (SYK) declined about 3% following earnings with Leerink trimming the price target to $407. Cramer cited a potential consolidator role for SYK, which has not materialized. The move occurs in a broader market context where FICO and CLOV fell while Vistra rose; with no definitive SYK catalyst, near-term action is driven by sentiment rather than fundamentals.

View signal analysis
Research

Company intelligence